Dabrafenib (Tafinlar®)

OncoLink Team
Last Modified: September 21, 2015

Pronounced: da braf' e nib
Classification: Kinase Inhibitor

About Dabrafenib

BRAF is a protein kinase that plays a role in regulating genes that are responsible for cell replication and survival. It is estimated that 50% of melanomas contain an abnormal form of BRAF (also called/known as a BRAF mutation). This mutated form of BRAF appears to promote overgrowth of these cancer cells. Dabrafenib works by blocking the actions of the abnormal BRAF, inhibiting cell replication and potentially causing cell death.

How to Take Dabrafenib

Dabrafenib is given in a capsule form and is typically taken twice a day, 12 hours apart, at the same times each day. Dabrafenib capsules should be taken on an empty stomach (1 hour before or 2 hours after eating) and should not be opened, crushed, broken or chewed. A missed dose can be taken up to 6 hours before the next scheduled dose. Do not take two doses at once to make up for a missed dose.

The blood levels of this medication can be affected by certain foods and medications, so they should be avoided. These include: grapefruit, grapefruit juice, verapamil, ketoconazole, rifampin, phenytoin, St. John’s wort, and modafanil.  Dabrafenib can also impact Coumadin (blood thinner) levels. 

If possible, you should not take this medication at the same time as "heartburn" medications (including proton pump inhibitors such as prilosec, nexium, protonix; H2 blockers, such as tagamet, zantac; and antacids, such as Tums, Rolaids) as these may effect how dabrafenib is absorbed. If you are taking Coumadin, you may require more frequent blood testing while taking dabrafenib. Be sure to tell your healthcare provider about all medications and supplements you take.

BRAF Testing

This medication only works in melanoma that has one of two specific BRAF mutations called V600E or V600K, and this abnormality must be tested for prior to starting the medication to identify patients appropriate for therapy. In order to test for mutated BRAF, a sample of the tumor is sent to a special laboratory that performs this test.

Storage and Handling

Store your medication in the original, labeled container at room temperature and in a dry location (unless otherwise directed by your healthcare provider or pharmacist). This medication should not be stored in a pillbox. Keep containers out of reach of children and pets.

If a caregiver prepares your dose for you, they should consider wearing gloves or pour the pills directly from their container into the cap, a small cup, or directly into your hand. They should avoid touching the pills. They should always wash their hands before and after giving you the medication. Pregnant or nursing women should not prepare the dose for you. Ask your oncology team where to return any unused medication for disposal. Do not flush down the toilet or throw in the trash.

Where do I get this medication?

Dabrafenib is available through select specialty pharmacies. Your oncology team will work with your prescription drug plan to identify an in-network specialty pharmacy for distribution of this medication and shipment directly to your home. 

Insurance Information

This medication may be covered under your prescription drug plan.  Patient assistance may be available to qualifying individuals without prescription drug coverage. Co-pay assistance, which reduces the patient’s co-pay responsibility may be available for eligible commercially (non-government sponsored) insured patients. Your care team can help you find these resources, if they are available.

Possible Side Effects

There are a number of things you can do to manage the side effects of dabrafenib. Talk to your doctor or nurse about these recommendations. They can help you decide what will work best for you. These are some of the most common side effects:


Fever can be a serious side effect of this medication. If you develop a fever of 101 or greater, call your healthcare team right away and before taking the next dose of medication.

New Skin Cancer

In clinical trials, some patients developed a new skin cancer (melanoma or squamous cell cancer). You should have skin examinations every 2 months while on therapy, and for 6 months after the medication has been stopped. Check your own skin regularly and report any new "warts", sores or bumps that bleed or do not heal, or notice any changes in moles to your healthcare provider.

Eye Issues

In clinical trials, several patients developed conditions called uveitis and iritis, which is a swelling or irritation of the middle layer and the colored part of the eye, respectively. Symptoms of this condition include blurry vision, loss of vision, seeing colored dots or "floaters" (dark spots in the field of vision), seeing a halo (blurred outline around objects), eye redness, swelling, or pain and sensitivity to light. In addition, a disorder called retinal pigment epithelial detachment (RPED) is associated with trametinib, which is often taken with dabrafenib. If you develop any of these symptoms or changes in your vision, notify your healthcare provider right away.

High Blood Sugar

This medication can cause elevated blood sugar levels in patients with and without diabetes. Your healthcare team will monitor your blood sugar. If you develop increased thirst, urination or hunger, blurry vision, headaches or your breath smells like fruit, notify your healthcare team. Diabetics should monitor their blood sugar closely and report elevations to the healthcare team.


Some patients may develop a rash, with or without itching, that can become severe or become infected if left untreated. Use an alcohol free moisturizer on your skin and lips; avoid moisturizers with perfumes or scents. If your skin does crack or bleed, be sure to keep the area clean to avoid infection. Be sure to notify your healthcare provider of any rash that develops, as this can be a serious reaction. They can give you more tips on caring for your skin and prescribe topical or oral therapy to help with the itching and rash.

This medication can also cause a reaction on the palms of the hands and soles of the feet that causes the skin to darken, become thickened, red, swollen or tender. Report these symptoms to your care provider. This too can be treated with topical medications that your care provider can recommend or prescribe.

Blood Clots

When used in combination with trametinib, dabrafenib can increase the risk of blood clots in your arms, legs or lungs (DVT, pulmonary embolism or PE).  Symptoms can include: swelling, redness, or pain in a leg or arm, chest pain or pressure, or shortness of breath. If you experience symptoms of these problems, you should contact your healthcare provider immediately or go to an emergency room.

Loss or Thinning of Scalp and Body Hair (Alopecia)

Your hair may become thin, brittle, or may fall out. This typically begins two to three weeks after treatment starts. This hair loss can be all body hair, including pubic, underarm, legs/arms, eyelashes, and nose hairs. The use of scarves, wigs, hats and hairpieces may help. Hair generally starts to regrow soon after treatment is completed. Remember your hair helps keep you warm in cold weather, so a hat is particularly important in cold weather or to protect you from the sun.


This medication, when used in combination with trametinib, may increase the risk of bleeding.  If you experience headaches, dizziness, cough up blood or blood clots, vomit blood or have red or black tar like looking stools, contact your care team immediately.

Heart Problems

Dabrafenib can cause heart problems, including heart failure.  Your healthcare team may check your baseline heart function before you start taking this medication. Notify your provider if you develop rapid weight gain, swelling of ankles or feet, shortness of breath, or feel like your heart is pounding or racing.

Hemolytic Anemia

Dabrafenib can cause the breakdown of red blood cells (hemolytic anemia) in people who have a G6PD deficiency, which is an inherited condition in which the body does not have enough of the enzyme glucose-6-phosphate dehydrogenase. You may not even be aware that you have this condition, therefore all patients taking this medication should report the following symptoms of red blood cell breakdown to their provider: jaundice (yellowing of the skin or whites of the eyes), weakness, dizziness or shortness of breath.


Fatigue is very common during cancer treatment and is an overwhelming feeling of exhaustion that is not usually relieved by rest. While on cancer treatment, and for a period after, you may need to adjust your schedule to manage fatigue. Plan times to rest during the day and conserve energy for more important activities. Exercise can help combat fatigue; a simple daily walk with a friend can help.  Talk to your healthcare team for helpful tips on dealing with this side effect.

Nausea and/or Vomiting

Talk to your doctor or nurse so they can prescribe medications to help you manage nausea and vomiting. In addition, dietary changes may help. Avoid things that may worsen the symptoms, such as heavy or greasy/fatty, spicy or acidic foods (lemons, tomatoes, oranges). Try antacids, (e.g. milk of magnesia, calcium tablets such as Tums), saltines, or ginger ale to lessen symptoms.

Call your doctor or nurse if you are unable to keep fluids down for more than 12 hours or if you feel lightheaded or dizzy at any time.


Your oncology team can recommend medications to relieve diarrhea. Also, try eating low-fiber, bland foods, such as white rice and boiled or baked chicken. Avoid raw fruits, vegetables, whole grain breads, cereals and seeds. Soluble fiber is found in some foods and absorbs fluid, which can help relieve diarrhea. Foods high in soluble fiber include: applesauce, bananas (ripe), canned fruit, orange sections, boiled potatoes, white rice, products made with white flour, oatmeal, cream of rice, cream of wheat, and farina. Drink 8-10 glasses on non-alcoholic, un-caffeinated fluid a day to prevent dehydration.

Headache, Muscle and Joint Pain/Aches

Your doctor or nurse can recommend medication and other strategies to relive pain.

Reproductive Concerns

Exposure of an unborn child to this medication could cause birth defects, so you should not become pregnant or father a child while on this medication. Effective birth control is necessary during treatment and for at least 4 months after stopping treatment. Even if your menstrual cycle stops or you believe you are not producing sperm, you could still be fertile and conceive.

Birth control using hormones (such as birth control pills, injections, or patches) may not work as well while you are taking dabrafenib. You should use another effective method of birth control while taking this medication.

This medication can affect a woman’s fertility and future ability to become pregnant. It can also cause lower sperm counts in men and may affect the ability to father a child. Talk with your healthcare provider about fertility preservation options. You should consult with your healthcare team before breastfeeding while receiving this medication.


Click on any of these terms for more related articles